This is the beginning of a new and exciting chapter. After its discovery more than 100 years ago, Allergen Immunotherapy (AIT) is entering a decade of fundamental regulatory changes, novel scientific data and - in general - great perspectives. No field of allergy has spiked more research ideas and clinical interest than the basics, modalities and practical applications of AIT. The EAACI Immunotherapy Interest Group (IT IG) is going to prepare the European Allergy Community for further advancement of this unique approach to cope with IgE-mediated allergic reactions and diseases.
This part of the EAACI website wishes to inform you about further activities of the EAACI IG Immunotherapy. The IG board is trying to stimulate the interest of our members, clinicians and scientists, encouraging them to walk the fascinating path of Allergen Immunotherapy, to the future.
Last updated 19 July 2015